CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 33.59% | -71.30% | EXIT | |
| 2 | AUTL | Autolus Therapeutics PLC | Stock-Other | 31.58% | -8.39% | EXIT | |
| 3 | PRTA | Prothena Corporation plc | Stock-Other | 15.69% | — | -26.42% | |
| 4 | NEOTEUR | Evofem Biosciences INC | Stock-Other | 15.43% | -20.31% | EXIT | |
| 5 | ✓ | Nucana PLC Sponsored Adr | Stock-Other | 3.72% | — | -34.45% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NEOTEUR | Evofem Biosciences INC | +12.2% | +18.97% | Add |
| 2 | TBPH | Theravance Biopharma, Inc. | +9.1% | -9.12% | Trim |
| 3 | PRTA | Prothena Corporation plc | +4% | -26.42% | Trim |
| 4 | AUTL | Autolus Therapeutics PLC | +1% | -3.71% | Trim |
| 5 | ✓ | Nucana PLC Sponsored Adr | -0.7% | -34.45% | Trim |
| 6 | AGIO | Agios Pharmaceuticals INC | — | EXIT | Sold out |
| 7 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 8 | BIIB | Biogen INC | — | EXIT | Sold out |